HopeStage
Back to all studies
RecruitingNCT03813290

Feasibility of a technology-based approach for teen anxiety

About this titleRead the official source — NCT03813290
Device studyAges 13–18Singapore
The study in practice

Understand this study

Who could participate?

This study is for people with anxiety. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.

Listed locations
SingaporeSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 8, 2020
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
National Healthcare Group, Singapore
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Singapore
Age range
From 13 Years to 18 Years
Official registry ID
NCT03813290
Official title
Show the full official title

A Neuro-Technological Intervention for Adolescents With Generalised Anxiety Disorder (GAD): A Feasibility Trial

Recruitment & locations

Currently recruiting

Singapore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Healthcare Group, Singapore.

Who can participate?

This study is for people with anxiety. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies